TABLE 1.
Patient demographicsa
| Characteristic | Graz (n = 79) (%) | Cardiff (n = 35) (%) |
|---|---|---|
| Age, mean (SD) (yr) | 63 (13) | 55 (18) |
| Female sex | 28 (35) | 16 (46) |
| Body mass index ≥30 kg/m2 | 21 (27) | 8 (23) |
| Underlying disease | ||
| Hematological malignancy | 13 (17) | 17 (49) |
| Solid organ transplantation | 8 (10) | 7 (20) |
| Cardiovascular disease | 52 (66) | 10 (29) |
| Pulmonary disease | 26 (33) | 9 (26) |
| Diabetes mellitus | 19 (24) | 15 (39) |
| Smoking status positive | 10 (13) | 8 (23) |
| Systemic corticosteroid therapy | 67 (85) | 18 (51) |
| ICU – respiratory support at time sample was obtained | ||
| Mechanical ventilation | 30 (38) | 25 (71) |
| Noninvasive ventilation | 15 (19) | |
| ECMO | 4 (5) | 0 (0) |
| CAPA | ||
| Possible | 0 | 2 |
| Probable | 3 | 3 |
| Proven | 0 | 0 |
| No evidenceb | 76 | 30 |
| Mortality - survival ICU discharge | 44 (56) | 23 (58) |
a
CAPA, COVID-19-associated pulmonary aspergillosis; ECMO, extracorporal membrane oxygenation; ICU, intensive care unit.
b
At time of plasma sampling for Karius test.